Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 31 | Childers Jason E.SVP, Information Technology |  WRLDWORLD ACCEPTANCE CORPOpen-market sale | SELL | $381K 2,000 sh | Aug 13, 2026 |
| 31 | Walsh ColinDirector |  ATTOAttovia Therapeutics, Inc.Open-market sale | SELL | $22K 988 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Raub ChristopherEVP JFI; CEO PPM America |  JXNJackson Financial Inc.Open-market sale | SELL | $653K 5,000 sh | Aug 13, 2026 traded Aug 12, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $9,649 443 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $2,211 100 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $4,410 200 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $29K 1,332 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $26K 1,180 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $2,199 100 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $23K 1,040 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $4,410 200 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $26K 1,163 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $34K 1,556 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $9,776 447 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $17K 753 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $8,808 400 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $10K 480 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $15K 672 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 31 | Walsh ColinDirector | ATTOAttovia Therapeutics, Inc. Open-market sale | SELL | $6,252 300 sh | Aug 13, 2026 traded Aug 5, 2026 |
| 29 | Lucas Stephen GSVP, Culture and Engagement |  KOPKoppers Holdings Inc.Open-market sale | SELL | $58K 1,308 sh | Aug 13, 2026 traded Aug 12, 2026 |
| 29 | Monroe Terilyn J.Chief People Officer | GHGuardant Health, Inc. Open-market sale | SELL | $605K 3,704 sh | Aug 13, 2026 traded Aug 12, 2026 |
| 29 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $284K 3,120 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 28 | Byers Deborah LDirector |  KNTKKinetik Holdings Inc.Open-market sale | SELL | $141K 2,739 sh | Aug 13, 2026 traded Aug 12, 2026 |
| 28 | Kuai JeffGeneral Manager, Pizza Hut |  YUMCYum China Holdings, Inc.Open-market sale | SELL | $206K 4,312 sh | Aug 13, 2026 traded Aug 12, 2026 |
| 28 | Ahmed AsmauDirector |  QNSTQUINSTREET, INCOpen-market sale | SELL | $104K 5,000 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 28 | Kuai JeffGeneral Manager, Pizza Hut | YUMCYum China Holdings, Inc. Open-market sale | SELL | $237K 4,961 sh | Aug 13, 2026 traded Aug 12, 2026 |
| 27 | McCarthy Cornelius P. IIIDirector |  MEDPMedpace Holdings, Inc.Open-market sale | SELL | $690K 1,140 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 26 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $55K 585 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 26 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $77K 845 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 26 | Kuzoyan VaheDirector, President |  TTANServiceTitan, Inc.Open-market sale · 10b5-1 plan | SELL | $4.39M 49.4K sh | Aug 13, 2026 traded Aug 11, 2026 |
| 24 | Burnett PatrickSee Remarks |  ARQTArcutis Biotherapeutics, Inc.Open-market sale | SELL | $220K 8,300 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 24 | Burnett PatrickSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale | SELL | $175K 6,700 sh | Aug 13, 2026 traded Aug 12, 2026 |
| 24 | Ahmed AsmauDirector | QNSTQUINSTREET, INC Open-market sale | SELL | $204K 10.0K sh | Aug 13, 2026 traded Aug 12, 2026 |
| 23 | Kuzoyan VaheDirector, President | TTANServiceTitan, Inc. Open-market sale · 10b5-1 plan | SELL | $259K 2,913 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 23 | Colgrove JohnDirector, Chief Visionary Officer |  PEverpure, Inc.Open-market sale · 10b5-1 plan | SELL | $997K 9,129 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 22 | Colgrove JohnDirector, Chief Visionary Officer | PEverpure, Inc. Open-market sale · 10b5-1 plan | SELL | $2.18M 21.1K sh | Aug 13, 2026 traded Aug 11, 2026 |
| 22 | Colgrove JohnDirector, Chief Visionary Officer | PEverpure, Inc. Open-market sale · 10b5-1 plan | SELL | $1.00M 9,459 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 22 | Kuzoyan VaheDirector, President | TTANServiceTitan, Inc. Open-market sale · 10b5-1 plan | SELL | $3.15M 35.4K sh | Aug 13, 2026 traded Aug 11, 2026 |
| 22 | Shah HusnalChief Product Officer |  FNKOFunko, Inc.Open-market sale | SELL | $1,201 200 sh | Aug 13, 2026 traded Aug 11, 2026 |
| 22 | Colgrove JohnDirector, Chief Visionary Officer | PEverpure, Inc. Open-market sale · 10b5-1 plan | SELL | $2.33M 22.4K sh | Aug 13, 2026 traded Aug 11, 2026 |